Connection

Giuseppe Curigliano to Administration, Metronomic

Back to Details
This is a "connection" page, showing publications Giuseppe Curigliano has written about Administration, Metronomic.
Giuseppe Curigliano
Connection Strength
0.047
Administration, Metronomic
  1. Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer (EORTC 75111-10114): an open-label, randomised, phase 2 trial from the Elderly Task Force/Breast Cancer Group. Lancet Oncol. 2018 03; 19(3):323-336.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.